Previous 10 | Next 10 |
DUBLIN, Ireland and TREVOSE, Pa., Oct. 17, 2019 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq: SBBP), a global commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for rare diseases with significant unmet needs, today announced t...
The following slide deck was published by Strongbridge Biopharma plc in conjunction with this Read more ...
DUBLIN, Ireland and TREVOSE, Pa., Sept. 25, 2019 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq: SBBP), a global commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for rare diseases with significant unmet needs, today announced ...
Arvinas (NASDAQ: ARVN ) initiated with Outperform rating and $38 (61% upside) price target at Wedbush. More news on: Arvinas, Inc., Minerva Neurosciences, Inc., Strongbridge Biopharma plc, Healthcare stocks news, Stocks on the move, , Read more ...
10x Genomics (NASDAQ: TXG ) initiated with Outperform rating and $70 (16% upside) price target at Evercore ISI. More news on: 10x Genomics, Inc., Aurora Cannabis Inc., Corcept Therapeutics Incorporated, Healthcare stocks news, Stocks on the move, , Read more ...
~ RECORLEV Resulted in Sustained Improvements in Urinary Free Cortisol (UFC) and Provided Clinical Benefit, As Demonstrated By Improvements in Comorbidities and Characteristic Signs and Symptoms of Cushing’s Syndrome ~ ~ RECORLEV Was Generally Well-Tolerated, With No Unexpect...
Aeterna Zentaris (AEZS) reported an awkward earnings report that exposed the fact that the company only pulled in ~0.2M in revenue, which was actually a slight miss. However, the company beat on EPS coming in at $0.01 vs. the expected -$0.14 EPS. The Q2 earnings were similar to the Q1 earnings...
Corcept Therapeutics Inc. ( CORT ) is a commercial-stage company discovering and developing drugs to modulate the effects of the stress hormone cortisol, for the treatment of severe metabolic, oncologic and psychiatric disorders. Corcept has an approved drug, Korlym (mifepristone), for Cushing...
The following slide deck was published by Strongbridge Biopharma plc in conjunction with this Read more ...
Gainers: LAKE +13.5% . ASPU +10.2% . CVIA +4.4% . AUPH +2.6%. BNFT +2.5% . More news on: Lakeland Industries, Inc., Aspen Group, Inc., Covia Holdings Corporation, Stocks on the move, , News on ETFs Read more ...
News, Short Squeeze, Breakout and More Instantly...
Strongbridge Biopharma plc Company Name:
SBBP Stock Symbol:
NASDAQ Market:
Strongbridge Biopharma plc Website:
DUBLIN, Ireland and TREVOSE, Pa., Oct. 05, 2021 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc (NASDAQ: SBBP) (the “Company” or “Strongbridge”) today announced that the High Court of Ireland (the "Court") has approved the previously announced proposed a...
DUBLIN, Ireland and TREVOSE, Pa., Sept. 23, 2021 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc (NASDAQ: SBBP) (the “ Company ” or “ Strongbridge ”) today announced that the High Court of Ireland (the “ Court ”) has set the dat...
DUBLIN, Ireland and TREVOSE, Pa., Sept. 08, 2021 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc (NASDAQ: SBBP) (the “ Company ” or “ Strongbridge ”) today announced that its shareholders have voted to approve the previously announced proposed ac...